By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted February 1, 2021APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2020 FINANCIAL RESULTS ON MARCH 31, 2021 READ MORE
By apyxmedical In 2021 Shareholder News, J-Plasma, RenuvionPosted January 13, 2021APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2020 REVENUE RESULTS READ MORE
By apyxmedical In 2020 Shareholder News, 2021 Shareholder News, J-Plasma, RenuvionPosted January 5, 2021APYX MEDICAL CORPORATION TO PARTICIPATE IN THE ICR CONFERENCE 2021 READ MORE
By apyxmedical In 2020 Shareholder News, Case Study, J-Plasma, RenuvionPosted November 23, 2020APYX MEDICAL CORPORATION ANNOUNCES APPROVAL FROM FDA TO BEGIN PHASE II OF U.S. IDE STUDY READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted November 9, 2020APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS READ MORE
By apyxmedical In 2020 Shareholder News, Case Study, J-Plasma, RenuvionPosted November 9, 2020APYX MEDICAL CORPORATION ANNOUNCES UPDATES ON U.S. IDE CLINICAL STUDIES READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted October 20, 2020APYX MEDICAL CORPORATION ANNOUNCES TWO PEER-REVIEWED CLINICAL PUBLICATIONS EVALUATING RENUVION’S HELIUM PLASMA TECHNOLOGY READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted October 1, 2020APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2020 FINANCIAL RESULTS ON NOVEMBER 9, 2020 READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted August 31, 2020APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER READ MORE
By apyxmedical In 2020 Shareholder News, J-Plasma, RenuvionPosted August 7, 2020APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS READ MORE
